Evolution and prospects for the definition of clinically useful endpoints in Sjögren disease

This publication has 45 references indexed in Scilit:

• Distinct Pathophysiologic Pathways Support Stratification of Sjögren's Disease Based on Symptoms, Clinical, and Routine Biological Data
  Arthritis & Rheumatology, 2025
• Efficacy and Safety of Low-Dose Interleukin 2 for Primary Sjögren Syndrome
  JAMA Network Open, 2022
• Content Validity of Sjögren’s Syndrome Symptom Diary and Functional Assessment of Chronic Illness Therapy-Fatigue in Patients with Sjögren’s
  Rheumatology and Therapy, 2022
• Symptom‐Based Cluster Analysis Categorizes Sjögren's Disease Subtypes: An International Cohort Study Highlighting Disease Severity and Treatment Discordance
  Arthritis & Rheumatology, 2022
• Randomized Controlled Trial of Rituximab and Cost‐Effectiveness Analysis in Treating Fatigue and Oral Dryness in Primary Sjögren's Syndrome
  Arthritis & Rheumatology, 2017
• Effects of Hydroxychloroquine on Symptomatic Improvement in Primary Sjögren Syndrome
  JAMA, 2014
• European League Against Rheumatism Sjögren's Syndrome Disease Activity Index and European League Against Rheumatism Sjögren's Syndrome Patient‐Reported Index: A Complete Picture of Primary Sjögren's Syndrome Patients
  Arthritis Care & Research, 2013
• Effectiveness of rituximab treatment in primary Sjögren's syndrome: A randomized, double‐blind, placebo‐controlled trial
  Arthritis & Rheumatism, 2010
• Etanercept in Sjögren's syndrome: A twelve‐week randomized, double‐blind, placebo‐controlled pilot clinical trial
  Arthritis & Rheumatism, 2004
• Inefficacy of infliximab in primary Sjögren's syndrome: Results of the randomized, controlled trial of remicade in primary Sjögren's syndrome (TRIPSS)
  Arthritis & Rheumatism, 2004